Correlation Between Mineralys Therapeutics, and Chinook Therapeutics
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Chinook Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Chinook Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Chinook Therapeutics, you can compare the effects of market volatilities on Mineralys Therapeutics, and Chinook Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Chinook Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Chinook Therapeutics.
Diversification Opportunities for Mineralys Therapeutics, and Chinook Therapeutics
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Mineralys and Chinook is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Chinook Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chinook Therapeutics and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Chinook Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chinook Therapeutics has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Chinook Therapeutics go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Chinook Therapeutics
Given the investment horizon of 90 days Mineralys Therapeutics, is expected to generate 16.93 times less return on investment than Chinook Therapeutics. But when comparing it to its historical volatility, Mineralys Therapeutics, Common is 1.32 times less risky than Chinook Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Chinook Therapeutics is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 2,256 in Chinook Therapeutics on August 27, 2024 and sell it today you would earn a total of 1,669 from holding Chinook Therapeutics or generate 73.98% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 34.96% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Chinook Therapeutics
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Chinook Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Mineralys Therapeutics, and Chinook Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Chinook Therapeutics
The main advantage of trading using opposite Mineralys Therapeutics, and Chinook Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Chinook Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chinook Therapeutics will offset losses from the drop in Chinook Therapeutics' long position.| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. HCW Biologics | Mineralys Therapeutics, vs. Scpharmaceuticals | Mineralys Therapeutics, vs. Milestone Pharmaceuticals |
| Chinook Therapeutics vs. Pliant Therapeutics | Chinook Therapeutics vs. Crinetics Pharmaceuticals | Chinook Therapeutics vs. Ascendis Pharma AS | Chinook Therapeutics vs. Ventyx Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |